Position in PCVX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,212,179,481
+$253,779,332 QoQ
Shares Held
20,852,907
+26.4% QoQ
Ownership
14.0%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1
of 329 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FMR LLC holds $61,424,667,385 across 370 Biotechnology names. PCVX ranks #11 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
5,231,452 | $4,853,584,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,023,962 | $4,522,663,276 | |
| 3 | MRNA |
Moderna, Inc.
|
51,859,891 | $3,631,748,165 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
81,020,390 | $2,867,311,601 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,200,422 | $2,284,895,029 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,631,956 | $1,953,067,789 | |
| 7 | INSM |
INSMED Inc
|
16,143,583 | $1,721,228,815 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,418,197 | $1,642,111,277 |
All Filings in PCVX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,209,040,405 | 20,798,906 | Shares | Sole | 2026-08-06 | |
| 2026-06-30 | $1,212,179,481 | 20,852,907 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $958,400,149 | 16,492,861 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $638,324,474 | 13,834,514 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $450,607,784 | 12,509,933 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $395,030,633 | 12,151,050 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $472,461,954 | 12,512,234 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,071,682,303 | 13,091,648 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,805,542,216 | 15,800,667 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,220,795,841 | 16,167,340 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,110,799,769 | 16,261,159 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $892,599,320 | 14,213,365 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $717,647,343 | 14,077,037 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $701,968,423 | 14,056,236 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $442,585,014 | 11,808,565 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $487,617,070 | 10,169,282 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $213,532,728 | 8,897,197 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $185,251,712 | 8,513,406 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $202,303,147 | 8,376,942 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $187,330,785 | 7,874,350 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $198,606,126 | 7,828,385 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $173,480,269 | 7,706,809 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $152,058,073 | 7,699,143 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $203,058,699 | 7,642,405 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $314,835,176 | 6,375,763 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $148,780,651 | 4,706,759 | Shares | Defined | 2020-08-24 | |
| No filing history on record for this holder in this stock. | ||||||